Lopinavir/Ritonavir plus nevirapine as a Nucleoside-sparing approach in antiretroviral-experienced patients (NEKA Study)

Citation metadata

Publisher: Lippincott Williams & Wilkins, WK Health
Document Type: Article
Length: 52 words

Document controls

Main content

Abstract :

A study is made to compare the efficacy and safety of a nucleoside sparing approach with a conventional highly active antiretroviral therapy (HAART) regimen in antiretroviral-experienced patients with prolonged viral suppression. The result showed that all patients maintained viral suppression after 48 weeks and no subject discontinued therapy because of adverse events.

Source Citation

Source Citation   

Gale Document Number: GALE|A132105703